1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine and HIV Coinfection

1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Edelman, K; Hooker, M; Muirhead, GJ; Rousseau, FS; Sereni, D; Williams, PE	1

Trials

1 trial(s) available for 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine and HIV Coinfection

Article	Year
Pharmacokinetics of 2-fluorodideoxycytidine (2FddC) in patients infected with human immunodeficiency virus. British journal of clinical pharmacology, 1993, Volume: 35, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antiviral Agents; Biological Availability; Drug Administration Schedule; HIV Infections; Humans; Injections, Intravenous; Male; Middle Aged; Zalcitabine	1993

Article

Year

Pharmacokinetics of 2-fluorodideoxycytidine (2FddC) in patients infected with human immunodeficiency virus.

British journal of clinical pharmacology, 1993, Volume: 35, Issue:3

Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antiviral Agents; Biological Availability; Drug Administration Schedule; HIV Infections; Humans; Injections, Intravenous; Male; Middle Aged; Zalcitabine

1993